Board change

Cambridge, UK, 3 June 2015: Sphere Medical Holding plc (AIM: SPHR.L), (“Sphere Medical” or the “Company”) a leading provider of innovative monitoring and diagnostic devices for the critical care setting, announces that on 3 June 2015 Matthew Hall, Chief Financial Officer, has given notice of his intention to leave the Company at the conclusion of the Company’s Annual General Meeting on 25 June 2015 in order to pursue other business interests.  Matthew will remain as a Consultant to the Company for a period of time in order to ensure a smooth transition and a search to appoint a new Chief Financial Officer is underway.

Dr. Anthony Martin, Non-Executive Chairman of Sphere Medical, said: “The Board would like to thank Matthew for his considerable contribution to the Company over the past four years. Matthew joined Sphere Medical prior to its IPO in November 2011 and since then has played a significant role in the continued development of the Company.  He was instrumental in concluding the collaboration agreement with Ortho-Clinical Diagnostics in July 2013 and the associated equity fundraising.  More recently Matthew has been a key part of the executive management team led by Wolfgang Rencken, which has orientated the business towards commercialisation of Proxima and earlier this year he was also integral to the £13.2 million placing and open offer which has provided the Company with the funds necessary to deliver near-term operational and commercial value drivers.  We wish him continued success in his future career."

Matthew Hall said: “I leave the Company with Proxima 3 being commercialised in the UK and Europe, the development of Proxima 4 nearing completion and a strong balance sheet to enable the Company to achieve its near-term milestones.  I firmly believe that Proxima has considerable potential in the intensive and critical care setting.”